Related Experiment Video

Updated: May 9, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.7K

Nirsevimab and Maternal Respiratory Syncytial Virus Vaccine Recommendations for the Pediatric Population

Anusha Panjwani, Jennifer S Katz, Robert K Katz

    Pediatric Annals
    |April 30, 2025
    PubMed

    Insights

    Protecting infants from respiratory syncytial virus (RSV) is critical. This review covers nirsevimab for infants and the RSVpreF vaccine for pregnant women, detailing best practices and challenges for RSV prevention.

    Area of Science:

    • Pediatrics
    • Immunology
    • Public Health

    Background:

    • Respiratory syncytial virus (RSV) poses a significant threat to infants under 12 months.
    • There is an urgent need for effective preventative measures against RSV in this vulnerable population.

    Purpose of the Study:

    • To review current evidence-based practices for RSV prevention in infants.
    • To highlight recommendations for the delivery of nirsevimab and the RSVpreF vaccine.
    • To address challenges faced by healthcare providers during the RSV season.

    Main Methods:

    • Literature review of current evidence-based practices.
    • Analysis of recommendations for nirsevimab (long-acting monoclonal antibody) and bivalent RSVpreF vaccine administration.
    • Identification of challenges in RSV prevention implementation.

    Main Results:

    • Nirsevimab and the RSVpreF vaccine are key interventions for infant RSV protection.
    • Evidence supports specific delivery strategies for these interventions.
    • Healthcare providers face challenges in optimal RSV season management.

    Conclusions:

    • Nirsevimab and the RSVpreF vaccine offer crucial protection against RSV for infants.
    • Effective implementation requires adherence to recommended practices and overcoming provider challenges.
    • Continued focus on evidence-based strategies is essential for reducing the burden of RSV.

    More Related Videos

    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

    Published on: December 10, 2013

    7.9K
    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

    Published on: April 4, 2019

    14.8K

    Related Concept Videos

    Common Respiratory Disorders01:31

    Common Respiratory Disorders

    Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
    Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
    124
    Upper Respiratory Drugs: First and Second-Generation Antihistamines01:15

    Upper Respiratory Drugs: First and Second-Generation Antihistamines

    Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
    Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
    131
    Drugs Used in Lower Respiratory Disorders: Overview01:17

    Drugs Used in Lower Respiratory Disorders: Overview

    Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
    Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
    242
    Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

    Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

    Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
    Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
    156
    Pneumonia V: Nursing management and Prevention01:30

    Pneumonia V: Nursing management and Prevention

    Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
    The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
    Enhance airway patency
    Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
    1.6K
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    263